ABVC BioPharma Inc. (ABVC)
NASDAQ · Healthcare
ABVC BioPharma Inc. Operating Income 2010–2025
ABVC BioPharma Inc. annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- ABVC BioPharma Inc. operating income for the quarter ending September 30, 2025 was -2.0 M, a 549.77% increase year-over-year.
- ABVC BioPharma Inc. operating income for the twelve months ending September 30, 2025 was -6.0 M, a 40.17% decrease year-over-year.
- ABVC BioPharma Inc. annual operating income for 2025 was -7.2 M, a 51.98% increase from 2024.
- ABVC BioPharma Inc. annual operating income for 2024 was -4.7 M, a 30.47% decrease from 2023.
- ABVC BioPharma Inc. annual operating income for 2023 was -6.8 M, a 55.23% decrease from 2022.
- ABVC BioPharma Inc. annual operating income for 2022 was -15.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ABVC BioPharma Inc. Operating Income — FAQ
ABVC BioPharma Inc. (ABVC) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is ABVC BioPharma Inc.'s operating income?
ABVC BioPharma Inc. (ABVC) reported operating income of -$7M for fiscal 2025.
Where can I see ABVC's operating income history?
The chart and table above show ABVC BioPharma Inc.'s operating income by year and by quarter, including the growth rate.